{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:09:13Z","timestamp":1783652953695,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Unsurprisingly, the subject of dementia has been a rising matter of public health concerns as people now live longer. World Alzheimer Report 2015, estimate that about 46.8 million people worldwide have dementia. These numbers are projected to almost double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050. The modality for treating agitation and other behavioral symptoms in dementia patients has been a challenge. Many years on, there has been no FDA-approved pharmacotherapy in treating dementia-related agitation. This review discusses the current knowledge of non-pharmacological interventions, and analyzes the risks and benefits of pharmacotherapy in the management of dementia-related agitation, as well as providing an anecdotal of the author's clinical experience. This article aims to provide opportunity for increase awareness for clinicians, particularly those with no specialty training in geriatrics medicine but see dementia patients with agitation and other behavioral symptoms from time to time. Likewise, it hopefully will benefit the readers of medical journals to update their existing knowledge on matters relating to the management of dementia-related agitation.<\/jats:p>","DOI":"10.1038\/tp.2017.199","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T15:04:09Z","timestamp":1509462249000},"page":"e1250-e1250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy"],"prefix":"10.1038","volume":"7","author":[{"given":"E O","family":"Ijaopo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"key":"BFtp2017199_CR1","unstructured":"Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. World Alzheimer Report 2015. The global impact of dementia. An analysis of prevalence, incidence, cost & trends. London: Alzheimer\u2019s Disease International (ADI); August 2015."},{"key":"BFtp2017199_CR2","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.jalz.2014.02.001","volume":"10","author":"Association As","year":"2014","unstructured":"Association As. Alzheimer's disease facts and figures. Alzheimer's Dement: J Alzheimer's Assoc 2014; 10: e47\u2013e92.","journal-title":"Alzheimer's Dement: J Alzheimer's Assoc"},{"key":"BFtp2017199_CR3","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","volume":"368","author":"MD Hurd","year":"2013","unstructured":"Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM . Monetary costs of dementia in the United States. N Engl J Med 2013; 368: 1326\u20131334.","journal-title":"N Engl J Med"},{"key":"BFtp2017199_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2010.01.009","volume":"6","author":"Association As","year":"2010","unstructured":"Association As. Alzheimer's disease facts and figures. Alzheimer's Dement 2010; 6: 158\u2013194.","journal-title":"Alzheimer's Dement"},{"key":"BFtp2017199_CR5","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1371\/journal.pmed.0050076","volume":"5","author":"C Ballard","year":"2008","unstructured":"Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med 2008; 5: e76.","journal-title":"PLoS Med"},{"key":"BFtp2017199_CR6","first-page":"284","volume":"40","author":"DA Casey","year":"2015","unstructured":"Casey DA . Pharmacotherapy of neuropsychiatric symptoms of dementia. P & T: Peer-rev J Formul Manag 2015; 40: 284\u2013287.","journal-title":"P & T: Peer-rev J Formul Manag"},{"key":"BFtp2017199_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J et al. Neuropsychiatric symptoms in Alzheimer's disease. Alzheimer's Dement 2011; 7: 532\u2013539.","journal-title":"Alzheimer's Dement"},{"key":"BFtp2017199_CR8","first-page":"218980","volume":"2015","author":"AMD Oliveira","year":"2015","unstructured":"Oliveira AMD, Radanovic M, Mello PCHD, Celestino DL, Forlenza OV, Buchain PC et al. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: a systematic review. BioMed Res Int 2015; 2015: 218980.","journal-title":"BioMed Res Int"},{"key":"BFtp2017199_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/gps.4137","volume":"30","author":"D Acharya","year":"2015","unstructured":"Acharya D, Harper DG, Achtyes ED, Seiner SJ, Mahdasian JA, Nykamp LJ et al. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia. Int J Geriatr Psychiatry 2015; 30: 265\u2013273.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3 Suppl. 1","key":"BFtp2017199_CR10","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1016\/j.jagp.2014.12.143","volume":"23","author":"E Jakobson","year":"2015","unstructured":"Jakobson E, Avari J, Kalayam B . Non-pharmacologic interventions for treatment of agitation in dementia in nursing home residents. Am J Geriatr Psychiatry 2015; 23 (3 Suppl. 1): S139\u2013S140.","journal-title":"Am J Geriatr Psychiatry"},{"key":"BFtp2017199_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12906-015-0612-9","volume":"15","author":"MH Yang","year":"2015","unstructured":"Yang MH, Lin LC, Wu SC, Chiu JH, Wang PN, Lin JG . Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation. BMC Complement Altern Med 2015; 15: 93.","journal-title":"BMC Complement Altern Med"},{"key":"BFtp2017199_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jamda.2014.12.016","volume":"16","author":"SA Hendriks","year":"2015","unstructured":"Hendriks SA, Smalbrugge M, Hertogh CMPM, van der Steen JT, Galindo-Garre F . From admission to death: prevalence and course of pain, agitation, and shortness of breath, and treatment of these symptoms in nursing home residents with dementia. J Am Med Dir Assoc 2015; 16: 475\u2013481.","journal-title":"J Am Med Dir Assoc"},{"key":"BFtp2017199_CR13","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2012.36918","volume":"308","author":"LN Gitlin","year":"2012","unstructured":"Gitlin LN, Kales HC, Lyketsos CG . Nonpharmacologic management of behavioral symptoms in dementia. J Am Med Assoc 2012; 308: 2020\u20132029.","journal-title":"J Am Med Assoc"},{"key":"BFtp2017199_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/13607863.2013.790926","volume":"17","author":"HM Ridder","year":"2013","unstructured":"Ridder HM, Stige B, Qvale LG, Gold C . Individual music therapy for agitation in dementia: an exploratory randomized controlled trial. Aging Mental Health 2013; 17: 667\u2013678.","journal-title":"Aging Mental Health"},{"key":"BFtp2017199_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0193945907305126","volume":"30","author":"P Hawranik","year":"2008","unstructured":"Hawranik P, Johnston P, Deatrich J . Therapeutic touch and agitation in individuals with Alzheimer's disease. West J Nurs Res 2008; 30: 417\u2013434.","journal-title":"West J Nurs Res"},{"key":"BFtp2017199_CR16","first-page":"66","volume":"11","author":"DL Woods","year":"2005","unstructured":"Woods DL, Craven RF, Whitney J . The effect of therapeutic touch on behavioral symptoms of persons with dementia. Altern Ther Health Med 2005; 11: 66.","journal-title":"Altern Ther Health Med"},{"key":"BFtp2017199_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/1472-6882-13-315","volume":"13","author":"DW O'Connor","year":"2013","unstructured":"O'Connor DW, Eppingstall B, Taffe J, van der Ploeg ES . A randomized, controlled cross-over trial of dermally-applied lavender (Lavandula angustifolia) oil as a treatment of agitated behaviour in dementia. BMC Complement Altern Med 2013; 13: 315.","journal-title":"BMC Complement Altern Med"},{"key":"BFtp2017199_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1192\/bjp.bp.113.141119","volume":"205","author":"G Livingston","year":"2014","unstructured":"Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N et al. Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. Br J Psychiatry 2014; 205: 436\u2013442.","journal-title":"Br J Psychiatry"},{"key":"BFtp2017199_CR19","doi-asserted-by":"publisher","first-page":"e012759","DOI":"10.1136\/bmjopen-2016-012759","volume":"7","author":"I Abraha","year":"2017","unstructured":"Abraha I, Rimland JM, Trotta FM, Dell'Aquila G, Cherubini A, Cruz-Jentoft A et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ Open 2017; 7: e012759.","journal-title":"BMJ Open"},{"key":"BFtp2017199_CR20","first-page":"Cd011882","volume":"4","author":"I Abraha","year":"2017","unstructured":"Abraha I, Rimland JM, Lozano-Montoya I, Dell'Aquila G, Velez-Diaz-Pallares M, Trotta FM et al. Simulated presence therapy for dementia. Cochrane Datab Syst Rev 2017; 4: Cd011882.","journal-title":"Cochrane Datab Syst Rev"},{"key":"BFtp2017199_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/gps.3924","volume":"28","author":"AC Vink","year":"2013","unstructured":"Vink AC, Slaets JPJ, Zuidersma M, De Jonge P, Boersma F, Zuidema SU . The effect of music therapy compared with general recreational activities in reducing agitation in people with dementia: a randomised controlled trial. Int J Geriatr Psychiatry 2013; 28: 1031\u20131038.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFtp2017199_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/jgs.13936","volume":"64","author":"E Jutkowitz","year":"2016","unstructured":"Jutkowitz E, Brasure M, Fuchs E, Shippee T, Kane RA, Butler M et al. Care-delivery interventions to manage agitation and aggression in dementia nursing home and assisted living residents: a systematic review and meta-analysis. J Am Geriatr Soc 2016; 64: 477\u2013488.","journal-title":"J Am Geriatr Soc"},{"key":"BFtp2017199_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jamda.2008.06.006","volume":"10","author":"SA Rappaport","year":"2009","unstructured":"Rappaport SA, Marcus RN, Manos G, Oren DA, McQuade RD . A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with alzheimer's, vascular, or mixed dementia. J Am Med Dir Assoc 2009; 10: 21\u201327.","journal-title":"J Am Med Dir Assoc"},{"key":"BFtp2017199_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2147\/NDT.S3201","volume":"4","author":"S Cakir","year":"2008","unstructured":"Cakir S, Kulaksizoglu IB . The efficacy of mirtazapine in agitated patients with Alzheimer's disease: a 12-week open-label pilot study. Neuropsychiatr Dis Treat 2008; 4: 963\u2013966.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFtp2017199_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/JGP.0b013e3181ab8c61","volume":"17","author":"LY Wang","year":"2009","unstructured":"Wang LY, Shofer JB, Rohde K, Hart KL, Hoff DJ, McFall YH et al. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatr Psychiatry 2009; 17: 744\u2013751.","journal-title":"Am J Geriatr Psychiatry"},{"key":"BFtp2017199_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000330032","volume":"1","author":"IA Lockhart","year":"2011","unstructured":"Lockhart IA, Orme ME, Mitchell SA . The efficacy of licensed-indication use of donepezil and memantine monotherapies for treating behavioural and psychological symptoms of dementia in patients with Alzheimer's disease: systematic review and meta-analysis. Dement Geriatr Cogn Dis Extra 2011; 1: 212\u2013227.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"BFtp2017199_CR27","doi-asserted-by":"publisher","first-page":"e35185","DOI":"10.1371\/journal.pone.0035185","volume":"7","author":"C Fox","year":"2012","unstructured":"Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A et al. Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial. PLoS ONE 2012; 7: e35185.","journal-title":"PLoS ONE"},{"key":"BFtp2017199_CR28","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1017\/S1041610213000239","volume":"25","author":"N Herrmann","year":"2013","unstructured":"Herrmann N, Gauthier S, Boneva N, Lemming OM . A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease. Int Psychogeriatr 2013; 25: 919\u2013927.","journal-title":"Int Psychogeriatr"},{"key":"BFtp2017199_CR29","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3892\/etm.2016.3284","volume":"12","author":"P Li","year":"2016","unstructured":"Li P, Quan W, Zhou Y-Y, Wang Y, Zhang H-H, Liu S . Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: a six-month, open-label, self-controlled clinical trial. Exp Ther Med 2016; 12: 492\u2013498.","journal-title":"Exp Ther Med"},{"key":"BFtp2017199_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1017\/S1041610212002141","volume":"25","author":"PT Trzepacz","year":"2013","unstructured":"Trzepacz PT, Cummings J, Konechnik T, Forrester TD, Chang C, Dennehy EB et al. Mibampator (LY451395) randomized clinical trial for agitation\/aggression in Alzheimer's disease. Int Psychogeriatr 2013; 25: 707\u2013719.","journal-title":"Int Psychogeriatr"},{"key":"BFtp2017199_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jama.2014.93","volume":"311","author":"AP Porsteinsson","year":"2014","unstructured":"Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. J Am Med Assoc 2014; 311: 682\u2013691.","journal-title":"J Am Med Assoc"},{"key":"BFtp2017199_CR32","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jama.2015.10214","volume":"314","author":"JL Cummings","year":"2015","unstructured":"Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW et al. Effect of Dextromethorphan-Quinidine on agitation in patients with alzheimer disease dementia: a randomized clinical trial. J Am Med Assoc 2015; 314: 1242\u20131254.","journal-title":"J Am Med Assoc"},{"key":"BFtp2017199_CR33","unstructured":"NICE. Management of aggression, agitation and behavioural disturbances in dementia: valproate preparations. Evidence summary: unlicensed or off-label medicine. National Institute for Health and Clinical Excellence (ESUOM41), 2015."},{"key":"BFtp2017199_CR34","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1001\/archinte.166.20.2182","volume":"166","author":"L Ayalon","year":"2006","unstructured":"Ayalon L, Gum AM, Feliciano L, Arean PA . Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med 2006; 166: 2182\u20132188.","journal-title":"Arch Intern Med"},{"key":"BFtp2017199_CR35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jgs.12730","volume":"62","author":"HC Kales","year":"2014","unstructured":"Kales HC, Gitlin LN, Lyketsos CG . Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc 2014; 62: 762\u2013769.","journal-title":"J Am Geriatr Soc"},{"key":"BFtp2017199_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002512-200825050-00003","volume":"25","author":"MJ Passmore","year":"2008","unstructured":"Passmore MJ, Gardner DM, Polak Y, Rabheru K . Alternatives to atypical antipsychotics for the management of dementia-related agitation. Drugs Aging 2008; 25: 381\u2013398.","journal-title":"Drugs Aging"},{"key":"BFtp2017199_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12888-016-0944-0","volume":"16","author":"B Lichtwarck","year":"2016","unstructured":"Lichtwarck B, Selbaek G, Kirkevold \u00d8, Rokstad AMM, Benth J, Myhre J et al. TIME - Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial. BMC Psychiatry 2016; 16: 233.","journal-title":"BMC Psychiatry"},{"key":"BFtp2017199_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/geront\/gnr081","volume":"52","author":"J Cohen-Mansfield","year":"2012","unstructured":"Cohen-Mansfield J, Jensen B, Resnick B, Norris M . Knowledge of and attitudes toward nonpharmacological interventions for treatment of behavior symptoms associated with dementia: a comparison of physicians, psychologists, and nurse practitioners. Gerontologist 2012; 52: 34\u201345.","journal-title":"Gerontologist"},{"key":"BFtp2017199_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jamda.2013.05.017","volume":"14","author":"MA Rapp","year":"2013","unstructured":"Rapp MA, Mell T, Majic T, Treusch Y, Nordheim J, Niemann-Mirmehdi M et al. Agitation in nursing home residents with dementia (VIDEANT trial): effects of a cluster-randomized, controlled, guideline implementation trial. J Am Med Dir Assoc 2013; 14: 690\u2013695.","journal-title":"J Am Med Dir Assoc"},{"key":"BFtp2017199_CR40","first-page":"975","volume":"7","author":"SL Blythe","year":"2009","unstructured":"Blythe SL, Chang E, Johnson A, Griffiths R . The efficacy of nurse implemented non-pharmacological strategies for the symptom management of agitation in persons with advanced dementia living in residential aged care facilities: a systematic review. JBI Lib Syst Rev 2009; 7: 975\u20131003.","journal-title":"JBI Lib Syst Rev"},{"key":"BFtp2017199_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/13607861003713190","volume":"14","author":"ML Cooke","year":"2010","unstructured":"Cooke ML, Moyle W, Shum DH, Harrison SD, Murfield JE . A randomized controlled trial exploring the effect of music on agitated behaviours and anxiety in older people with dementia. Aging Mental Health 2010; 14: 905\u2013916.","journal-title":"Aging Mental Health"},{"key":"BFtp2017199_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/gps.1688","volume":"22","author":"PWK Lin","year":"2007","unstructured":"Lin PWK, Ng BFL, Chan WC, Lam LCW . Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross-over randomized trial. Int J Geriatr Psychiatry 2007; 22: 405\u2013410.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFtp2017199_CR43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1017\/S1041610212002128","volume":"25","author":"ES Van Der Ploeg","year":"2013","unstructured":"Van Der Ploeg ES, Eppingstall B, Runci SJ, O'Connor DW, Camp CJ, Taffe J . A randomized crossover trial to study the effect of personalized, one-to-one interaction using Montessori-based activities on agitation, affect, and engagement in nursing home residents with dementia. Int Psychogeriatr 2013; 25: 565\u2013575.","journal-title":"Int Psychogeriatr"},{"key":"BFtp2017199_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/scs.12240","volume":"30","author":"M Van Vracem","year":"2016","unstructured":"Van Vracem M, Spruytte N, Declercq A, Van Audenhove C . Agitation in dementia and the role of spatial and sensory interventions: experiences of professional and family caregivers. Scand J Caring Sci 2016; 30: 281\u2013289.","journal-title":"Scand J Caring Sci"},{"key":"BFtp2017199_CR45","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1532-5415.2009.02271.x","volume":"57","author":"LC Lin","year":"2009","unstructured":"Lin LC, Yang MH, Kao CC, Wu SC, Tang SH, Lin JG . Using acupressure and Montessori-based activities to decrease agitation for residents with dementia: a cross-over trial. J Am Geriatr Soc 2009; 57: 1022\u20131029.","journal-title":"J Am Geriatr Soc"},{"key":"BFtp2017199_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/WAD.0b013e3181630b6f","volume":"22","author":"A Raglio","year":"2008","unstructured":"Raglio A, Bellelli G, Traficante D, Gianotti M, Ubezio MC, Villani D et al. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord 2008; 22: 158\u2013162.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"BFtp2017199_CR47","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1365-2702.2005.01218.x","volume":"14","author":"HC Sung","year":"2005","unstructured":"Sung HC, Chang AM . Use of preferred music to decrease agitated behaviours in older people with dementia: a review of the literature. J Clin Nurs 2005; 14: 1133\u20131140.","journal-title":"J Clin Nurs"},{"key":"BFtp2017199_CR48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.JGP.0000300629.35408.94","volume":"16","author":"LN Gitlin","year":"2008","unstructured":"Gitlin LN, Winter L, Burke J, Chernett N, Dennis MP, Hauck WW . Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study. Am J Geriatr Psychiatry 2008; 16: 229\u2013239.","journal-title":"Am J Geriatr Psychiatry"},{"key":"BFtp2017199_CR49","doi-asserted-by":"publisher","first-page":"681304","DOI":"10.1155\/2013\/681304","volume":"2013","author":"PH Koulivand","year":"2013","unstructured":"Koulivand PH, Khaleghi Ghadiri M, Gorji A . Lavender and the nervous system. Evid Based Complement Alternat Med 2013; 2013: 681304.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"Supplement S1","key":"BFtp2017199_CR50","first-page":"S240","volume":"63","author":"NL Jain","year":"2015","unstructured":"Jain NL, Ehwarieme R, Kusz HG . Dementia related behavioral problems: when less can do more in managing a difficult patient. J Am Geriatr Soc 2015; 63 (Supplement S1): S240.","journal-title":"J Am Geriatr Soc"},{"key":"BFtp2017199_CR51","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/1471301215613779","volume":"16","author":"KD Ray","year":"2015","unstructured":"Ray KD, Mittelman MS . Music therapy: a nonpharmacological approach to the care of agitation and depressive symptoms for nursing home residents with dementia. Dementia 2015; 16: 689\u2013710.","journal-title":"Dementia"},{"key":"BFtp2017199_CR52","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/1533317513494444","volume":"28","author":"S Janzen","year":"2013","unstructured":"Janzen S, Zecevic AA, Kloseck M, Orange JB . Managing agitation using nonpharmacological interventions for seniors with dementia. Am J Alzheimers Dis Other Dement 2013; 28: 524\u2013532.","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"BFtp2017199_CR53","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1017\/S104161021200172X","volume":"25","author":"J Cohen-Mansfield","year":"2013","unstructured":"Cohen-Mansfield J, Juravel-Jaffe A, Cohen A, Rasooly I, Golander H . Physicians' practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes. Int Psychogeriatr 2013; 25: 236\u2013244.","journal-title":"Int Psychogeriatr"},{"key":"BFtp2017199_CR54","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1017\/S1041610209990196","volume":"21","author":"KS Kverno","year":"2009","unstructured":"Kverno KS, Black BS, Nolan MT, Rabins PV . Research on treating neuropsychiatric symptoms of advanced dementia with non-pharmacological strategies, 1998-2008: a systematic literature review. Int Psychogeriatr 2009; 21: 825\u2013843.","journal-title":"Int Psychogeriatr"},{"key":"BFtp2017199_CR55","unstructured":"Eapcnet.eu. Recommendations on palliative care and treatment of older people with Alzheimer\u2019s disease and other progressive dementias. European Association for Palliative Care; 2013."},{"key":"BFtp2017199_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0269216313493685","volume":"28","author":"JT Van Der Steen","year":"2014","unstructured":"Van Der Steen JT, Hertogh CM, De Boer ME, Francke AL, Junger S, Radbruch L et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med 2014; 28: 197\u2013209.","journal-title":"Palliat Med"},{"key":"BFtp2017199_CR57","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jpainsymman.2013.05.015","volume":"47","author":"SA Hendriks","year":"2014","unstructured":"Hendriks SA, Smalbrugge M, Hertogh CMPM, Van Der Steen JT . Dying with dementia: symptoms, treatment, and quality of life in the last week of life. J Pain Symptom Manage 2014; 47: 710\u2013720.","journal-title":"J Pain Symptom Manage"},{"key":"BFtp2017199_CR58","unstructured":"Food & Drug Administration FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. US Food and Drug Administration: Rockville, MD, 2012."},{"key":"BFtp2017199_CR59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/S1041610212001627","volume":"25","author":"DP Seitz","year":"2013","unstructured":"Seitz DP, Gill SS, Herrmann N, Brisbin S, Rapoport MJ, Rines J et al. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. Int Psychogeriatr 2013; 25: 185\u2013203.","journal-title":"Int Psychogeriatr"},{"key":"BFtp2017199_CR60","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","volume":"294","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, Dagerman KS, Insel P . Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. J Am Med Assoc 2005; 294: 1934\u20131943.","journal-title":"J Am Med Assoc"},{"key":"BFtp2017199_CR61","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","volume":"146","author":"SS Gill","year":"2007","unstructured":"Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146: 775\u2013786.","journal-title":"Ann Intern Med"},{"key":"BFtp2017199_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00023210-200519020-00001","volume":"19","author":"N Herrmann","year":"2005","unstructured":"Herrmann N, Lanctot KL . Do atypical antipsychotics cause stroke? CNS Drugs 2005; 19: 91\u2013103.","journal-title":"CNS Drugs"},{"key":"BFtp2017199_CR63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jamda.2009.10.001","volume":"11","author":"JJ Jalbert","year":"2010","unstructured":"Jalbert JJ, Eaton CB, Miller SC, Lapane KL . Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc 2010; 11: 120\u2013127.","journal-title":"J Am Med Dir Assoc"},{"key":"BFtp2017199_CR64","doi-asserted-by":"publisher","first-page":"e98426","DOI":"10.1371\/journal.pone.0098426","volume":"9","author":"LT Drye","year":"2014","unstructured":"Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL et al. Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. PLoS ONE 2014; 9: e98426.","journal-title":"PLoS ONE"},{"key":"BFtp2017199_CR65","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bcp.12997","volume":"82","author":"T Ho","year":"2016","unstructured":"Ho T, Schantz O, Bies R, Pollock BG, Mulsant BH, Devanand DP et al. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. Br J Clin Pharmacol 2016; 82: 784\u2013792.","journal-title":"Br J Clin Pharmacol"},{"key":"BFtp2017199_CR66","unstructured":"Intra-Cellular Therapies, Inc. ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease. (ClinicalTrials.gov National Library of Medicine (US), [Internet] Bethesda (MD), 2008. [Cited April 10, 2017]. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02817906."},{"key":"BFtp2017199_CR67","unstructured":"University of Sussex. A Pragmatic, Multi Centre, Double-blind, Placebo Controlled Randomised Trial to Assess the Safety, Clinical and Cost Effectiveness of Mirtazapine or Carbamazepine in Patients With Alzheimer's Disease (AD) and Agitated Behaviours (ClinicalTrials.gov National Library of Medicine (US), [Internet] Bethesda (MD) (2008) [Cited April 2, 2017]. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03031184."},{"key":"BFtp2017199_CR68","unstructured":"Avanir Pharmaceuticals. A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]\/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type (ClinicalTrials.gov National Library of Medicine (US), [Internet]. Bethesda (MD) (2017). [Cited April 10, 2017]. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02442765."},{"key":"BFtp2017199_CR69","unstructured":"Otsuka Pharmaceutical Co., Ltd. A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole in the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type (ClinicalTrials.gov National Library of Medicine (US), [Internet] Bethesda (MD) (2017). [Cited April 10, 2017]. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02168920."},{"key":"BFtp2017199_CR70","unstructured":"Acadia Pharmaceuticals Inc. A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (ClinicalTrials.gov National Library of Medicine (US), [Internet] Bethesda (MD), (2016). [Cited April 5, 2017]. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02992132."},{"key":"BFtp2017199_CR71","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1017\/S1041610212000798","volume":"24","author":"ES van der Ploeg","year":"2012","unstructured":"van der Ploeg ES, Mbakile T, Genovesi S, O'Connor DW . The potential of volunteers to implement non-pharmacological interventions to reduce agitation associated with dementia in nursing home residents. Int Psychogeriatr 2012; 24: 1790\u20131797.","journal-title":"Int Psychogeriatr"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2017199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017199","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tp.2017.199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:08:59Z","timestamp":1671728939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2017199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":71,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10]]}},"alternative-id":["BFtp2017199"],"URL":"https:\/\/doi.org\/10.1038\/tp.2017.199","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]},"assertion":[{"value":"21 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}